ϩ CD4 ϩ CD25 ϩ(Bright) "natural" regulatory T cells (nT reg cells) are abundant in rabbit conjunctiva and suppress herpes simplex virus (HSV)-1-specific CD4 ϩ and CD8 ϩ effector T cells (T eff cells). However, little is known about the overall regulatory mechanisms of these nT reg cells. The authors investigate the regulation of conjunctiva-resident nT reg cells through Toll-like receptors (TLRs) and their effect on ocular mucosal T eff cell immunity.
RESULTS.
The authors found that conjunctiva-resident nT reg cells express high levels of TLR2 and TLR9; exposure to the TLR2 ligand lipoteichoic acid (LTA) led to the increased activation and proliferation of nT reg cells, and the addition of autologous APCs further increased nT reg cell expansion; in contrast, the TLR9 ligand CpG 2007 inhibited the proliferation of nT reg cells, and the addition of autologous APCs had no effect on such inhibition; nT reg cells treated with LTA, but not with CpG 2007 , expressed IFN-␥ and IL-10 mRNA, but not TGF-␤; consistent with in vitro data, rabbits immunized by topical ocular drops of HSV-gD peptides ϩ TLR2 ligand (LTA) displayed enhanced CD4 ϩ CD25 Ϫ T eff cell immune responses when compared with HSV-gD peptides ϩ TLR9 ligand (CpG 2007 ).
CONCLUSIONS. Although conjunctiva-resident CD4
ϩ
CD25
ϩ nT reg cells express high level of TLR2 and TLR9, their suppressive function is more significantly reversed after the administration of TLR2 ligand (LTA; P Ͻ 0.005) than of TLR9 ligand (CpG 200 ; P Ͼ 0.005). These findings will likely help optimize the topical ocular administration of immunotherapies. (Invest Ophthalmol Vis Sci. 2011;52:3321-3333) DOI:10.1167/iovs. R egulatory T cells (T reg ) constitute a phenotypically and functionally distinct ␣␤ T cell population that represents 1% to 2% of peripheral mononuclear cells and 5% to 10% of all peripheral CD4
ϩ T cells in both mice and humans. 1,2 Naturally occurring CD4 ϩ CD25 ϩ regulatory T cells (also known as nT reg ) have emerged as a dominant regulatory T cell subpopulation mediating peripheral adaptive immune tolerance and suppression of immunity against many pathogens. [2] [3] [4] [5] [6] [7] In general, most nT reg cells constitutively express high-affinity IL-2R␣ receptor (i.e., CD25) and the transcription factor forkhead/ winged-helix transcription factor (Foxp3) molecules. 8, 9 In addition, in the resting state, they constitutively express several activation markers, such as glucocorticoid-induced receptor TNF-R (GITR), OX40 (CD134), and CTLA-4. 10, 11 The mucosal epithelia and underlying lamina propria contain large numbers of regulatory T cells that play an important role in maintaining mucosal homeostasis and defense against external pathogens. 12 We recently described an abundance of "natural" Foxp3 ϩ
CD4
ϩ CD25 ϩ(Bright) nT reg cells in "nonimmune" rabbit conjunctiva, the main inductive site of the ocular mucosal immune system. 1 We demonstrated that conjunctiva-resident nT reg cells suppress herpes simplex virus type 1 (HSV-1)-specific CD4 ϩ and CD8
ϩ effector T cells (T eff ). Converging evidence, from our laboratory and other laboratories, demonstrates that nT reg cells have the potential to dampen the vaccine-induced, HSVspecific, T eff -mediated immunity. [13] [14] [15] [16] Despite recent extensive studies on nT reg cells, the molecular mechanism by which nT reg cells mediate the suppression of pathogen-specific T cell immunity or dampen vaccine-induced T eff cells remains poorly understood.
Recent discovery of Toll-like receptors (TLRs) has provided the link between the innate and adaptive immune systems. [17] [18] [19] At least 13 TLRs that recognize a limited but conserved set of ligands from viral, bacterial, protozoan, and helminth pathogens have now been identified in mice and humans. 20 -23 It was initially thought that TLRs are primarily expressed by antigen-presenting cells (APCs) such as macrophages and dendritic cells and that interactions between microbial ligands and TLRs in these cells would indirectly result in the activation of effector T cells (T eff cells). However, it has become evident that TLRs are also expressed by conventional ␣␤ T cells, regulatory T cells, and ␥␦T cells and by natural killer T cells. 21,24 -26 A correlation between nT reg cell-suppressive function and TLR expression has been documented. [27] [28] [29] Although some TLR ligand-receptor interactions have been proposed to increase nT reg cell suppressive capacity, others have been shown to limit such function. 28,30 -32 For example, TLR2 signaling temporally abrogates the suppressive phenotype of nT reg cells and decreases Foxp3 expression. 33, 34 A direct involvement of TLR-5 on nT reg cell immunosuppressive function has been demonstrated recently. 28 TLR9 ligand CpG DNA also modulates adaptive immune responses by inhibiting the suppressive effects of nT reg cells in mice. 32 However, the phenotypic and functional characterization of TLRs, particularly on conjunctiva-resident nT reg cells, has not been reported.
In the present study, we examined the expression profile of TLRs on conjunctiva-resident nT reg cells and assessed whether TLRs are functionally active by assessing whether stimulation of these nT reg cells with TLR agonists, in the absence of APCs, would result in modification of their regulatory functions. We show that rabbit conjunctiva-resident CD4 ϩ CD25 ϩ nT reg cells express high levels of functional TLR2 and TLR9. Topical ocular immunization of rabbits with HSV-gD peptide T cell epitopes, together with a TLR2 ligand (LTA), reverses CD4 ϩ
CD25
ϩ nT reg cell suppressive function. In contrast, topical ocular immunization of rabbits with the same epitopes delivered with a TLR9 ligand (CpG 2007 ) resulted in only a slight effect on CD4 ϩ
ϩ nT reg cell suppressive function. Our findings demonstrate that regulating conjunctiva CD4 ϩ
ϩ nT reg cell function trough TLR2 and TLR9 is possible and leads to the modulation of ocular mucosal HSV-specific CD4 ϩ
Ϫ T eff cell responses. The potential use of TLR agonists for steering ocular mucosal T cell responses in a topical ocular therapeutic vaccine strategy is discussed.
MATERIALS AND METHODS

Rabbits
For in vitro studies, healthy rabbit eyes with palpebral conjunctiva were purchased from Pel Freeze Biologicals (Rogers, AR). For in vivo studies, 7-week-old New Zealand White female rabbits (Harlan, Indianapolis, IN) were used for all experiments. Rabbits were maintained under specific pathogen-free conditions in the animal facilities of the University of California at Irvine.
Media, Reagents, and Antibodies
Cells were cultured in RPMI-1640 supplemented with 10% heat-inactivated FCS, 100 IU/mL penicillin, 100 g/mL streptomycin, 2 mM L-glutamine, and 1 mM Na-pyruvate at 37°C, 5% CO 2 incubator. Lipoteichoic acid (LTA) and phytohemagglutinin were purchased from Sigma. CpG 2007 was purchased from Coley Pharmaceutical Group (Wellesley, MA). Anti-human TLR2-PE, TLR3-PE, TLR4-PE, TLR8-PE, and TLR9-PE monoclonal antibodies were purchased from Imgenex (San Diego, CA). Purified anti-human CD3 was purchased from R&D Systems (Minneapolis, MN). CFSE was purchased from Invitrogen (Carlsbad, CA). Anti-rabbit CD4, anti-rabbit CD25, and goat anti-mouse IgG-PE were purchased from Antigenix America (Melville, NY). Rabbit anti-mouse IgG-PE was purchased from Serotec (Raleigh, NC). Monoclonal anti-rabbit CD11b-PE, CD11b-FITC, CD11c-PE, and CD11C-FITC were purchased from Chemicon (Temecula, CA). Pam3CSK4 was purchased from Imgenex (catalog no. IMG-2201). PE-conjugated antihuman Foxp3 was purchased from e-Bioscience (San Diego, CA; catalog no. 12-4776-71). Purified anti-human Foxp3 was purchased from BioLegend (San Diego, CA; catalog no. 320101).
Purification of CD4
؉ CD25 ؉ and CD4 ؉ CD25 ؊ Cells
Single cell suspension from healthy rabbit conjunctiva was prepared as previously described. 1 CD4 ϩ CD25 ϩ nT reg cells were purified from conjunctiva-derived single cell suspension by positive selection with magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). In brief, 18 to 20 ϫ 10 7 single cell suspension in 2 mL MACS buffer (Miltenyi Biotec) was first incubated with 100 to 120 L anti-rabbit CD25-biotin followed by a second incubation with 360 L anti-biotin microbeads (Miltenyi Biotec) according to manufacturer's instructions. CD25 ϩ cells were subsequently eluted from the MACS column. The flow-through containing 9 to 10 ϫ 10 7 CD25 ϩ cells was collected and further purified by two successive incubations, the first with 100 L anti-rabbit CD4-FITC and the second with 100 L anti-FITC microbeads (Miltenyi Biotec) according to manufacturer's instructions. CD4 
Purification of CD11b ؉ Cells
Single cell suspension from healthy rabbit conjunctiva was prepared as described earlier. 1 Cells were plated in a T75 flask at a density of 10 ϫ 10 6 /20 mL culture media and were allowed to attach for 2 hours at 37°C in a 5% CO 2 incubator. Nonattached cells were removed by aspiration. Attached cells were gently washed two times with culture media, scraped, and collected in culture media. Trypan blue staining was used to check cell viability. 
Intracellular Staining of TLRs
Purified CD4 ϩ CD25 ϩ cells (0.24 ϫ 10 6 cells/100 L culture medium) were washed and suspended in FACS staining buffer (PBS [pH 7.4] containing 0.5% BSA, 0.02% sodium azide). Cells were stained with 1 L anti-rabbit CD25-biotin for 30 minutes at room temperature, washed, and further incubated with 1 L anti-strepatavidin-Cy5 (Chemicon) for 30 minutes at 4°C in the dark. Cells were washed twice with FACS staining buffer. For intracellular staining, cells were fixed with fixation-permeabilization buffer (e-bioscience) according to the manufacturer's instruction. Cells were then stained with 3 L antihuman TLR2-PE, TLR3-PE, TLR4-PE, TLR8-PE, and TLR9-PE for 30 minutes at 4°C in the dark. Cells were washed twice with FACS staining buffer and analyzed by flow cytometry (FACScan; BD Biosciences, San Jose, CA). The acquired data were analyzed by acquisition and analysis software (Cell Quest; BD Biosciences).
Intracellular Staining of Foxp3
Harvested CD4 ϩ CD25 ϩ cells (0.5 ϫ 10 6 cells/assay) from a 96-well tissue culture plate were washed and suspended in FACS staining buffer (PBS [pH 7.4] containing 0.5% BSA, 0.02% sodium azide). Cells were surface stained with anti-rabbit CD4-FITC (10 L/assay) for 30 minutes at 4°C in the dark. For intracellular staining, cells were fixed as described and were stained with anti-human foxp3-PE (20 L/assay) for 30 minutes at 4°C in the dark. The rest of the procedure was same as described.
CFSE Labeling of CD4
؉ CD25 ؉ Cells . Autologous APCs were always treated with 1 g/mL mitomycin C for 45 minutes at 37°C and were washed five times before they were put into the culture. Cells in all three sets were plated in triplicate and incubated for 6 days at 37°C in a 5% CO 2 incubator. Cells were harvested, washed twice with FACS staining buffer, and stained with anti-rabbit CD4-PE or anti-rabbit CD25-PE and analyzed by flow cytometry. The absolute number of proliferating cells was calculated using the formula (No. events in CD4 ϩ proliferating cells) ϫ (No. events in gated cells)/(No. total events acquired).
Ex Vivo Assay
Six New Zealand White female rabbits (two per group) were immunized ocularly (both eyes) with a mixture of four HSV-gD peptides (gD 146 -179 , gD 287-317 , gD 49 -82 , and gD 200 -234 ) along with either TLR ligand CpG 2007 (group 1) or LTA (group 2), or not immunized (group 3), at an interval of 14 days. The amount of each HSV-gD peptide in the peptide mixture was 25 g and was suspended in 100 L sterile PBS. The amount of CpG 2007 or LTA in the peptide mixture was 25 g/100 L peptide mixture. Each rabbit was immunized with 100 L (50 L/eye) peptide mixture. Ten days after the third immunization, the conjunctiva was removed from each rabbit eye, and a single cell suspension was prepared as described earlier.
1 CFSE-labeled, conjunctiva-derived, single cell suspensions were plated at a density of 3 ϫ 10 5 cells in 200 L in a 96-well, round-bottomed tissue culture plate, stimulated with individual HSV-gD peptide (10 g/mL) or nonspecific positive control phytohemagglutinin (10 g/mL) and were incubated for 5 days at 37°C in a CO 2 incubator. Cells were harvested and stained with anti-rabbit CD4-PE and analyzed by flow cytometry.
Cytokine Expression Quantification Using Real-Time PCR
Purified nT reg cell lysate was suspended directly in RLT buffer (Qiagen, Valencia, CA). This lysate was then processed over RNeasy columns according to the manufacturer's instructions (Qiagen). The RNA was eluted from the silica column with 50 L DEPC-treated water. One microliter of the product was analyzed (2100 Bioanalyzer; Agilent, Wilmington, DE) using the nano-RNA protocol to verify both the quantity and the quality of the RNA. RNA obtained from purified nT reg cells was converted to cDNA using a synthesis protocol (Sensiscript; Qiagen). For these, 1000 ng RNA was reverse transcribed in a 20-L reaction volume after wiping out the genomic DNA. Reactions were carried out for 30 minutes at 42°C, followed by 5 minutes at 95°C and cooling to 4°C. After synthesis, the cDNA from all sources was diluted to equivalent input RNA levels with water (10 ng input RNA/L) and was stored at Ϫ20°C until use. cDNA samples were subjected to PCR using specific primers. Primers were designed with a software program (Primer 3 Internet; The Whitehead Institute, Cambridge, MA), 35 and their specificities were confirmed by a BLAST Internet software-assisted search of the nonredundant nucleotide sequence database (National Library of Medicine, Bethesda, MD). The following primers were used for cytokine detection: IFN-␥: sense, 5Ј-CATCAGATGTG-GCAAATGGT-3Ј; forward, 5Ј-ATCCACCGAAATTCGAGTCA-3Ј; IL-10: sense, 5Ј-AAAAGCTAAAAGCCCCAGGA-3Ј; forward, 5Ј-ATAGGATCG-GGAGCTGAGGT-3Ј; TGF-␤: sense, 5Ј-TGCTTCAGCTCCACAGAGAA-3Ј; forward; 5CTTGCTGTACTGGGTGTCCA-3Ј.
All PCR reactions were carried out with 5 ng reverse-transcribed RNA, 200 nM each forward and reverse primer, and master mix (SYBR Green; Applied Biosystems, Foster City, CA) in a final volume of 25 L. Cycling parameters were 50°C for 2 minutes and 95°C for 5 minutes, followed by 45 cycles of 95°C for 30 seconds and 60°C for 90 seconds. Plates were read after each cycle, and a melting curve was generated after amplification. For quantitative real-time PCR, samples were normalized by GADPH amplification and were amplified in triplicate using a thermal cycler (Opticon; MJ Research, Waltham, MA). PCR controls without reverse transcriptase (water control) or with normal human genomic DNA as a template were routinely negative. Cytokine expression were carried out using a 2-⌬⌬CT method, as recently described. 
Statistical Analysis
All analyses for statistically significant differences were performed with the Student's paired t-test. P Ͻ 0.05 was considered significant. All cultures were performed in triplicate, and error bars represented standard deviation.
RESULTS
Conjunctiva-Resident CD4
؉ CD25 ؉ T Cells Express High Levels of TLR2 and TLR9
CD4
ϩ CD25 ϩ T cells were purified from normal rabbit conjunctiva by magnetic cell separation, as we described previously. 1 The expression of TLR2, TLR3, TLR4, TLR8, and TLR9 by conjunctiva-resident CD4 ϩ CD25 ϩ T cells was determined by intracellular staining and analyzed by flow cytometry. As shown in Figure 1A , conjunctiva-derived CD4 ϩ CD25 ϩ T cells expressed detectable amounts of all tested TLRs. Further analysis of mean fluorescence intensity (MFI) of each TLR revealed significantly higher expression levels of TLR2 and TLR9 compared with TLR3, TLR4, and TLR8 (P Ͻ 0.005; Fig. 1C ). Given that no anti-rabbit TLR mAbs were commercially available, we used a mouse anti-human TLR IgG 1 mAb to detect the TLR expression profile in rabbits. The specificity of anti-human TLR mAbs to detect TLR in rabbit CD4 ϩ CD25 ϩ T cells was verified by an isotype mAb control. Figure 1B shows 
CD25
Ϫ T eff cells, which was copurified along with the magnetic separation of CD4 ϩ CD25 ϩ nT reg cells from rabbit conjunctiva. Figure 1D showed a significantly lower expression of TLR2 (MFI Ͻ50) in CD4 ϩ CD25 Ϫ T eff cells compared with the TLR2 expression in CD4 ϩ CD25 ϩ nT reg cells (MFI Ͼ250) shown in Figure 1C . Interestingly, no significant differences in the expression level of TLR9 between these two cell populations (i.e., CD4 ϩ CD25 ϩ nT reg cells and CD4 ϩ CD25 Ϫ T eff cells) were observed (Figs. 1C, 1D ). This indicates the integrity of the CD4 ϩ CD25 ϩ T reg cell and CD4 ϩ CD25 Ϫ T eff cell populations.
We next investigated whether the intracellular expression of TLR2 and TLR9 was comparable to that of APCs, an immune cell population known for high expression of TLRs. We tested the expression levels of TLRs in CD11b/c ϩ APCs isolated from healthy rabbit conjunctiva. Figure 2A shows the histogram representation of all tested TLRs in autologous CD11b/c ϩ APCs, and Figure 2B shows their corresponding MFI. Autologous CD11b/c
ϩ APCs also expressed all tested TLRs, and the highest expression was observed for TLR9 (MFI Ն500 Figure 3A shows that the proliferation of CD4 ϩ CD25 ϩ nT reg cells was enhanced approximately twofold after stimulation with soluble anti-human CD3 (P Ͻ 0.005). Interestingly, the addition of LTA further enhanced the overall proliferation of CD4 ϩ CD25 ϩ nT reg cells (P Ͻ 0.005). In contrast, a decrease (rather than an enhancement) in the absolute number of proliferating nT reg cells was observed when CpG 2007 was used.
Next we assessed whether the addition of autologous APCs would affect the proliferation of anti-CD3 stimulated nT reg cells. Purified CD4 ϩ CD25 ϩ nT reg cells were stimulated in the presence of both soluble anti-CD3 and autologous APCs, in the presence of soluble anti-CD3 alone, or in the presence of media alone (control). As expected, the proliferation of nT reg was enhanced twofold to threefold when incubated with both anti-CD3 and autologous APCs compared with anti-CD3 without autologous APCs (Fig. 3B vs. Fig. 3A ). The addition of LTA to these APC/CD4 ϩ CD25 ϩ cocultures, along with anti-human CD3, further enhanced the proliferation by a factor of 10-fold compared with media alone (without anti-human CD3 or APCs To determine whether conjunctiva-resident nT reg cells in "anergic" and "stimulated" states are able to produce IFN-␥, IL-10, and TGF-␤, we checked their expression profiles by real-time PCR. Unfortunately, there are no kits available to detect rabbit cytokines and growth factor by ELISA. Conjunctiva-purified nTreg cells were pretreated with LTA for 6 hours, followed by incubation with anti-CD3 and IL-2 for another 6 hours at 37°C. Cells were harvested, and mRNA expression of IFN-␥, IL-10, and TGF-␤ were measured by real-time PCR. Figure 4 shows that LTA-pretreated and anti-CD3/IL-2-stimulated nT reg cells expressed 2.5-fold more IFN-␥ (Fig. 4A ) and IL-10 ( Fig. 4B ) mRNA than untreated nT reg cell controls (i.e., ␣ CD3 ϩ IL-2 without LTA; P Ͻ 0.05). However, LTA pretreatment did not affect TGF-␤ (Fig. 4C) nT reg cells with LTA alone, without CD3 ϩ IL-2, was unable to induce significant levels of IFN-␥, IL-10, or TGF-␤ mRNAs compared with untreated nT reg cells (medium). These results suggest that LTA-TLR2 interaction might transform nT reg cells from an anergic state to an active state. Unlike LTA, CpG 2007 treatment has no effect of on cytokine production by nT reg cells (Figs. 4D-F Figure 5A , the addition of CD4 ϩ CD25 ϩ nT reg cells at a ratio of 1:2 to CD4 ϩ CD25 Ϫ T eff cells resulted in a significant suppression of CD4 ϩ CD25 Ϫ T eff cell proliferation (P Ͻ 0.005). The results presented in Figure  5A were also expressed as the percentage of proliferation in Figure 5B . This CFSE-labeled suppression assay result confirmed our previous observation 1 
TLR2 Ligand LTA Enhances the Immunogenicity of HSV-1 gD-Derived Peptide Antigen Delivered Topically to the Conjunctiva
Next we compared the adjuvant effect of TLR2 and TLR9 ligands on topical ocular mucosal immunogenicity of the HSV-1 gD peptide epitope. Rabbits were immunized by topical application of a mixture of four immunodominant CD4 ϩ T cell peptide epitopes (gD 144 -179 , gD 287-317 , gD 49 -82 , and TGF-␤ (C, F) expression in rabbit conjunctiva-purified CD4 ϩ CD25 ϩ cells using realtime PCR. One million nT reg cells were plated in a six-well tissue culture plate and were pretreated with LTA (10 g/mL; A-C) or CpG (1 g/ mL; D-F) for 12 hours, followed by stimulation for another 12 hours in the presence of anti-CD3 (1 g/mL) and IL-2 (20 U/mL) at 37°C. RNA was isolated from harvested cells and was quantified. An equal amount of RNA was reversed transcribed. cDNA was amplified using real time PCR and specific primers for rabbit INF-␥, IL-10, and TGF-␤. GAPDH was used as a housekeeping gene. RNA quantification was calculated using the comparative Ct method, also known as the 2-⌬⌬Ct method, where ⌬⌬Ct ϭ ⌬Ct sample Ϫ ⌬Ct reference (none). Here, ⌬CT sample is the Ct value for any sample normalized to the endogenous housekeeping gene, and ⌬Ct reference (none) is the Ct value for the calibrator also normalized to the endogenous housekeeping gene.
TLR2 Ligand Pam3CSK4, but Not LTA, Affects Foxp3 Expression in Conjunctiva-Resident CD4
؉ CD25 ؉ nTreg Cells
We investigated whether treatment with TLR2 ligands (LTA and Pam3CSK4) or TLR9 ligand (CpG) would affect Foxp3 expression in rabbit conjunctiva CD4 ϩ CD25 ϩ Treg cells. A slight increase in Foxp3 expression was detected, by both flow cytometry (Figs. 7A, 7B ) and Western blot analysis (Fig. 7C) , after CpG treatment. However, no significant changes in the Foxp3 level were observed after LTA treatment. Interestingly, treatment of rabbit conjunctiva CD4 ϩ CD25 ϩ Treg cells with a different TLR2 ligand, Pam3CSK4, induced a significant decrease in the level of Foxp3 (P Ͻ 0.005).
DISCUSSION
It was initially thought that TLRs are primarily expressed by APCs, such as macrophages and dendritic cells, and that interactions between microbial ligands and TLRs expressed by APCs would indirectly result in activation of effector T cells. However, it has now become evident that TLRs are also expressed by various T cell subsets, such as conventional ␣␤ T eff cells, T reg cells, and ␥␦ T cells and by natural killer T cells. 38 Importantly, it appears that at least in some of these T cell subsets, TLRs are functionally active because stimulation of these cells with TLR agonists in the absence of APCs results in the exertion of effector or regulatory functions of T cells. In the present study, we provided evidence for the dominating expression of TLR2 and TLR9, over other TLRs, by conjunctiva-resident nT reg cells and demonstrated their functional relevance with respect to ocular mucosal T cell immunity. To our knowledge, this is the first report describing the phenotypic expression and functional property of TLRs by conjunctiva-resident T cells.
Most data on mucosal T reg cells originated from mouse models (see Ref. 12 for review). Because of the obvious ethical and practical considerations in studying human ocular mucosal T reg cells, a critical question has been which species would be the most appropriate animal model to investigate conjunctiva T reg cells. 39, 40 Instead of mice we elected rabbit as the working animal model, bearing in mind that numerous similarities exist between rabbit and human ocular mucosal tissues 40 -42 ; several T cell-mediated ocular surface diseases, including herpetic conjunctivitis and recurrent corneal herpetic stromal keratitis (HSK), have been reported to be similar in rabbits and humans, making it the most relevant animal model for exploring these human eye disorders [43] [44] [45] ; compared with mice, rabbit conjunctiva-associated lymphoid tissue (CALT) more closely resembles human CALT 46 -48 ; microanatomy and immunohistologic studies indicate that rabbit conjunctival mucosa is comparable to that of humans and has a typical follicular ultrastructure with an abundance of conjunctival lymphoid follicles, whereas no lymphoid tissue was identified in mice and rats 48 -52 ; from a practical standpoint, unlike mice, rabbits have a relatively large conjunctival surface, offering abundant MALT for in vitro studies; finally, the recent availability of many monoclonal and polyclonal antibodies specific to rabbit immune cell CD markers, cytokines, and growth factors provides useful immunologic tools for an unprecedented phenotypic and functional analysis of rabbit T cell repertoire and function.
Rabbit conjunctiva-purified CD4 ϩ CD25 ϩ T reg cells display an increased level of TLR expression, especially TLR2 compared with autologous CD4 ϩ CD25 Ϫ T eff cells, suggesting that the expansion and suppression function of T reg cells may be closely regulated by TLR2 ligands. In general, T reg cells express higher levels of TLR2, TLR4, TLR5, TLR7/8, and TLR10 than conventional CD4 ϩ CD25 Ϫ T eff cells. 28 -31,34,38,53,54 TLR10 is constitutively expressed at both mRNA and protein levels in T reg cells but not in T eff cells. 55 On the other hand, TLR3 is not detectable in T reg cells, whereas it is expressed by T eff cells. 38, 56 Several recent reports indicate direct sensing of "danger" signals by T cells (instead of APCs). This direct recognition of TLR ligands may play a role in T cell homeostasis and effector function. In particular, a crucial role of TLR2 activation in the functional properties of T reg cells has been demonstrated in a series of reports showing that TLR2 ligand temporarily abrogates the immunosuppressive effects of murine T reg cells and reduces the level of Foxp3 expression in T reg cells and activates the expansion of dysfunctional T reg cells. 30, 34, 38 Here we found that engagement of TLR2 on rabbit conjunctival T reg cells with its specific ligand, LTA, induced their proliferation (Fig. 3) and reversed their immunosuppressive function (Fig.  5) . Questions might arise whether this downregulation of immunosuppression effect is due to an engagement of LTA on T reg cells or a direct effect on T eff . Although we cannot rule out the latter possibility, the probability is low because autologous rabbit T eff cells express fivefold to sixfold less TLR2 than T reg cells (Fig. 1D) autologous APCs (data not shown). In contrast to TLR-2, the expression level of TLR9 on both T reg and T eff cells is more or less similar (Figs. 1C, 1D ). In the T reg cell proliferation assay, when TLR9 is engaged with the specific ligand CpG, we observed a significant inhibition of T reg cell proliferation (Fig. 3) . However, in the suppression assay (Fig. 5) , CpG reversed the immunosuppressive capability of T reg cells, but at lesser extent than LTA. Whether this reduced effect of CpG in the suppression assay was caused by a simultaneous engagement of TLR9 on both T reg or T eff cells remains to be determined. Nevertheless, in a separate experiment, we have shown that CpG did not affect the proliferation of CD4 ϩ CD25 Ϫ T eff cells in the presence of soluble anti-CD3 and autologous APCs, thus excluding a direct effect on T eff cells (data not shown). Our results are consistent with recent finding by Chiffoleau et al. 57 showing that triggering TLR9 on human T reg cells inhibits their immunosuppressive function but does not induce their proliferation or the downregulation of their Foxp3 expression. In that study the loss of suppression was in part due to the effect of TLR9 ligand on T eff cells, but it is not clear whether TLR9 ligand directly influences T reg cells.
In this study we found that conjunctiva-resident CD4 ϩ CD25 ϩ nT reg cells express relatively high levels of TLR2 (MFI ϳ260), a moderate level of TLR9 (MFI ϳ115), and very low levels of TLR3, TLR4, and TLR8 (MFI Ͻ50). In parallel, we checked the expression profile of the same set of TLRs in the copurified fraction of CD4 ϩ CD25 Ϫ T eff cells and found extremely low levels (MFI Ͻ50) for TLR3, TLR4, and TLR8 and a relatively higher level of TLR9 (MFI ϳ88) expression. This indicated that, with the exception of TLR9, the other TLRs expression on T eff cells was statistically insignificant in the ocular mucosal conjunctiva. To determine whether the expression level of TLRs on conjunctiva-resident nT reg cells was comparable with other immune cells known for high TLR expression, we evaluated the TLR expression profile in autologous APCs. Our data show that conjunctiva-resident CD11b level was extremely high and was expressed four to five times more (MFI Ն500) than the expression of TLR9 (MFI Ն100) on nT reg cells. It is interesting that though a differential level of TLR9 expression was observed in two different immune cells, such as CD11b ϩ APCs and nT reg cells of same conjunctival origin, the TLR2 expression level remained similar in both types of cells. This suggests that TLR2 is a more conserved type of toll receptor within the immune cells present in the mucosal conjunctiva tissue. However, in humans and mice, TLR4, TLR5, and TLR8, but not TLR2, are preferentially expressed on CD4 ϩ CD25 ϩ T reg cells. 28 -31,34,38,53,54 This highlights a striking phenotypic difference between mucosa and non-mucosa nT reg cells. A similar observation of TLR2 and TLR9 expression in ocular epithelial cells was reported by Chang et al. 58 To our knowledge, there are thus far two reports of TLR2 expression on CD4 ϩ CD25 ϩ T reg cells in humans and mice. 30, 33 Although TLR expression patterns and magnitudes varied within the tissue and species, 59, 60 in rabbit, the selective high expression of TLR2 on conjunctiva-resident nT reg cells is certainly a unique situation.
It has been shown that TLR ligands influence the immunosuppressive function of nT reg cells either through a direct interaction with TLRs specifically expressed on T reg cells 31 or an indirect mechanism mediated by dendritic cells. 61 In (Fig 5B) , they also expressing higher levels of IL-10 and IFN-␥ mRNA, which is not conventional for nT reg cells. A similar effect was reported by Sutmuller et al. 30, 33 The TLR2 ligand Pam3Cys-SK4 forced T reg cells into the proliferative pathway, which was paralleled by a transient loss of suppressive activity, and they regained their suppression once cells were back in the resting phase. 30, 33 One possible explanation for the loss of suppression by LTA would be the higher production of IFN-␥ by nT reg cells when stimulated in the presence of LTA/anti-CD3/IL-2 (Fig. 4A) . We have also detected higher expression of TGF-␤ in nT reg cultures stimulated with LTA/anti CD3/IL-2 (Fig. 4C) , thus confirming previous reports. 62 However, controversial data about the role of TGF-␤ in nT reg cells have also been reported. 63 The most prominent characteristics of nT reg cells are their nonresponsiveness toward TCR stimulation in the presence of anti-CD3. However, our in vitro data (Fig. 3A) showed that the proliferation of nT reg cells was slightly increased by anti-CD3 irrespective of the presence of either LTA or CpG or the addition of APCs in the culture. This suggested that nT reg cells might not be equally anergic in all tissues and species. HSV infections occur at the ocular mucosal tissues and lead to self-limiting primary disease. 64 Foreign HSV antigens promote immune responses when coadministered with TLR ligands, which have been exploited as immune adjuvants promoting protective T cells and antibody responses. 65, 66 Here we compared the potential efficacy of LTA and CpG as candidate immune adjuvants in the rabbit eye model and showed that although both CpG 2007 and LTA are capable of inducing local CD4 ϩ T eff cell responses, these responses were better in the presence of LTA. Collectively, these results strongly suggest that TLR2 signals contribute to the activation and expansion of nT reg cells (Fig. 3) and interfere with their suppressive activity (Fig. 5) . Consequently, this led to an increase the magnitude of HSV-gD-peptide-specific T eff cell responses in vivo (Fig. 6) . As suggested by Conroy et al. 67 the nT reg cell function is more like a "double-edged sword" that can lead to an outcome that is context dependent. Under these circumstances, greater understanding of the modulation and regulation of T reg cells in the rabbit ocular immune system is critical to understand their complete biological role.
It has been shown that though TLR2, TLR8, or TLR9 ligation abrogates or reverses the immunosuppressive function of CD4 ϩ CD25 ϩ T reg cells, TLR2, TLR4, or TLR5 ligation enhances the suppressive capacity of CD4 ϩ CD25 ϩ T reg cells. 68 Leu et al. 33 recently showed that in the presence of a TLR2 agonist, such as the synthetic bacterial lipoprotein Pam3Cys-SK4, there was marked expansion of CD4 ϩ CD25 ϩ T reg cells, but their immunosuppressive function was temporarily abrogated. This study suggests that the downregulation of Foxp3 could be a putative mechanism for the abrogation of T reg cell-mediated suppression. 33, 69 Treatment of CD4 ϩ CD25 ϩ T reg cells with heat shock protein 60 (the in vivo ligand of TLR2) suppressed target T eff cells both by cell-cell contact mechanisms and by the secretion of cytokines such as TGF-␤ and IL-10.
70 TLR2 activation on T reg cells using the synthetic ligand PAM3Cys, in combination with IL-2 and TCR triggering, can induce T reg proliferation and results in temporary loss of suppression. On removal of the TLR2 ligand, the T reg cells regained their immunosuppressive function. 27, 30, 71, 72 This discrepancy could possibly be explained by the nature of the TLR ligands used (PAM3Cys is an exogenous TLR1/2 ligand and hsp60 is an endogenous TLR2 ligand), the concentrations of the ligands used, or differences in the ways endogenous and exogenous ligands interact with TLR2. TLR8 also directly reverses the immunosuppressive function of CD4 ϩ CD25 ϩ T reg cells.
29
TLR8 is strongly and preferentially expressed on human T reg cells compared with human T eff cells. 29 Triggering TLR8 on T reg cells resulted in the specific abrogation of suppression without affecting T reg cell proliferation, though no effects on human T eff cells were observed. 29 Applying siRNA technology to knockdown TLR8 on T reg cells completely blocked the effect, demonstrating a crucial role for TLR8. 29 Several studies, using mouse-or human-derived CD4 ϩ
CD25
ϩ Treg, pointed to an interplay between TLRs and Foxp3. 73 In humans, the engagement of TLR5 by its ligand flagellin leads to the upregulation of Foxp3 expression in Treg and consequently enhances their suppressive activity. 28, 74, 75 In contrast, TLR9 engagement by CpG did not affect Foxp3 expression in Treg although it abrogated their suppressive function. 32, 57, 76 Although the effect of most TLR engagement on Foxp3 expression and Treg-suppressive function appears to be settled for many TLRs, conflicting results have been reported in mice on the effect of TLR2 engagement on Foxp3 expression on Treg. Some studies showed that Foxp3 expression was downregulated after TLR2 ligation by the synthetic bacterial triacylated lipopeptide Pam 3 CSK4. 30, 33 Chen et al. 77 recently challenged this report by showing that treatment of Treg with Pam 3 CSK4 neither affected the level of Foxp3 expression on Treg cells nor abolished its suppressive function. This discrepancy could be explained by the use of different TLR2 ligands in each study that might lead to the use of different heterodimers, the possibility that there are species-specific differences in the control of Treg cell activity by same TLR2 ligands, and the fact that differences might be linked to the origin of Treg in each study (i.e., peripheral vs. mucosal-derived Treg). In contrast to the murine system, TLR2 ligand-mediated abrogation of human Treg function was not associated with a downregulation of Foxp3. 73 Nevertheless, our data ( Fig. 7) showed some increase in Foxp3 expression when TLR9 was engaged with CpG. However, no significant changes in Foxp3 expression were observed when TLR2 was engaged with LTA. Interestingly, the engagement of TLR2 with a different ligand Pam3CSK4 significantly decreased the Foxp3 expression on rabbit Treg.
In humans, the LTA ligand engages the TLR2/TLR6 combination, whereas Pam3Cys engages TLR2/TLR1. 78 In mice, the Pam 3 CSK4 ligand engages either the TLR2/TLR1 combination or TLR2 independently of TLR1. Furthermore, Hajjar et al. 79 reported on the recognition of triacylated lipopeptides in a TLR2/TLR1-dependent fashion in human cells. In the presence of the Pam3CSK4 ligand, a stable heterodimer is formed between TLR2 and TLR1. 80 Therefore, though both LTA and Pam3CSK4 are ligands for TLR2, the former engages TLR2/ TLR6 and the latter engages TLR2/TLR1 combinations. Nevertheless, recent data by Carpenter and colleagues 81 recently showed that engagement of either TLR2/TLR1 or TLR2/TLR6 combinations activate the same NF-B downstream signal pathway. To our knowledge, the present study is first to report the expression and functional engagement of any TLR on rabbit Treg cells. We demonstrated that engagement of TLR-2 on rabbit Treg cells with LTA and Pam3CSK4 differentially affects the expression of Foxp3 (Fig. 7) , suggesting that, as with human Treg cells, these ligands might interact with either TLR2/TLR1 or TLR2/TLR6 combination. Given that most of the TLR data come from mice and humans, there is a possibility that LTA and Pam3CSK4 ligands might have different effects on rabbit TLR2/TLR-1 and TLR2/TLR-6 combinations and downstream intracellular pathways. This will be the subject of future reports.
In conclusion, the results reported here suggest a link between the TLR2 and its exogenous ligand LTA and how nT reg cells in ocular mucosal tissue regulate cellular immunity in response to viral antigen. These findings might be useful in clinical settings to enhance the efficacy of immunotherapy directed toward infectious diseases. CD4 ϩ T cell help is required for the generation of primary CTL responses and the promotion of protective CD8 ϩ memory T cell development. Recent studies 82, 83 demonstrated a previously unappreciated role of CD4 help in mobilizing effector CD8 ϩ CTL to the peripheral sites of infection. Our results reveal a previously unappreciated role of CD4 ϩ CD25 ϩ nT reg cells in interfering with CD4 ϩ CD25 Ϫ T eff cells at the ocular mucosal sites of herpes infection, where they might help to eliminate herpesinfected cells. Ongoing and future research will further delineate the mechanisms involved in interactions between these two subsets of T cells and innate receptors and will pave the way for developing better prophylactic or therapeutic strategies for control of infectious, allergic, and autoimmune ocular diseases.
